Phoenix Clinical Research website – https://www.phoenix-cr.com/ is a regional dynamic full-service Contract Research Organization (CRO) established in Lebanon. Its objective is to cover the whole Middle East and North Africa region. Phoenix CR key asset is Read more…
Mesenchymal Stem Cells
Advancements in mesenchymal stem cell (MSC) research are shedding light on how these stem cells may someday be used in various clinical applications such as immunomodulatory therapies (i.e., prevention of graft-versus-host disease or treatment of Crohn’s disease) and in cell replacement therapies for mesenchymal tissues such as bone and cartilage.
We offer an extensive selection of specialty products optimized for mesenchymal stem cell populations.
Stem Cell Differentiation Services
From pluripotent stem cell (PSC) to terminally differentiated cells in as little as 3 to 6 weeks. Provide your own cells or have us reprogram somatic cells into PSCs.
Stem Cell Screening Services
Get compounds screened for your stem cell-based discovery projects in our high-throughput screening facilities.
Stem Cell Characterization Services
Let us confirm cell identity, pluripotency, gene expression, and other characteristics of stem cells.
Induced Pluripotent Stem Cells
The discovery in 2006 that human and mouse fibroblasts could be reprogrammed to generate induced pluripotent stem cells (iPSCs) with qualities remarkably similar to embryonic stem cells has created a valuable new source of pluripotent cells for drug discovery, cell therapy, and basic research.
Our stem cell research products have been an integral part of iPSC research from the initial discovery of iPSCs to current breakthroughs. Our broad technology platform provides optimized tools for each step of the stem cell workflow: from reprogramming somatic cells to iPSC expansion, validation, and differentiation.
Get in Touch
We are working 24 hours a day, 7 days a week
Registered office address:
27 Old Gloucester Street, London, WC1N 3AX
Mon - Fri, 10:00-20:00